Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Frank Behrens

Treatment to Target in Psoriatic Arthritis With Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

Arthritis Care and Research

Rheumatology

2020

English

Ixekizumab Is Efficacious When Used Alone or When Added to Conventional Synthetic Disease-Modifying Antirheumatic Drugs (cDMARDs) in Patients With Active Psoriatic Arthritis and Previous Inadequate Response or Intolerance to Tumour Necrosis Factor Inhibitors

English

Individual Therapeutic DAS28-dcrit Responses Differentiate Between Effectiveness of Rheumatoid Arthritis Therapies and Reflect Patient-Reported Outcomes: Retrospective Analysis of DAS28 Responses in Comparative Tocilizumab Studies

Rheumatology International

English

Related publications

COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Nature Reviews Immunology

English

Sterile Inflammation: Sensing and Reacting to Damage

Nature Reviews Immunology

English

DAMP-driven Metabolic Adaptation

Nature Reviews Immunology

English

The Regulation of IL-10 Production by Immune Cells

Nature Reviews Immunology

English

Complement as a Target in COVID-19?

Nature Reviews Immunology

English

The Function of Fcγ Receptors in Dendritic Cells and Macrophages

Nature Reviews Immunology

English

Monocyte Recruitment During Infection and Inflammation

Nature Reviews Immunology

English

Signalling Pathways That Control Vertebrate Haematopoietic Stem Cell Specification

Nature Reviews Immunology

English

Heat Shock Proteins Are No DAMPs, Rather 'DAMPERs'

Nature Reviews Immunology

English

Standardization in Flow Cytometry: Correct Sample Handling as a Priority

Nature Reviews Immunology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Frank Behrens

Treatment to Target in Psoriatic Arthritis With Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

Ixekizumab Is Efficacious When Used Alone or When Added to Conventional Synthetic Disease-Modifying Antirheumatic Drugs (cDMARDs) in Patients With Active Psoriatic Arthritis and Previous Inadequate Response or Intolerance to Tumour Necrosis Factor Inhibitors

Individual Therapeutic DAS28-dcrit Responses Differentiate Between Effectiveness of Rheumatoid Arthritis Therapies and Reflect Patient-Reported Outcomes: Retrospective Analysis of DAS28 Responses in Comparative Tocilizumab Studies

Related publications

COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Sterile Inflammation: Sensing and Reacting to Damage

DAMP-driven Metabolic Adaptation

The Regulation of IL-10 Production by Immune Cells

Complement as a Target in COVID-19?

The Function of Fcγ Receptors in Dendritic Cells and Macrophages

Monocyte Recruitment During Infection and Inflammation

Signalling Pathways That Control Vertebrate Haematopoietic Stem Cell Specification

Heat Shock Proteins Are No DAMPs, Rather 'DAMPERs'

Standardization in Flow Cytometry: Correct Sample Handling as a Priority